Peptide library › Immune & inflammation
Thymosin Alpha-1
Also known as Thymalfasin, Zadaxin, Tα1
Thymus-derived immune-modulating peptide approved in several countries.
What people use it for
- Chronic hepatitis B and C (approved in some countries)
- Immune support (popular use)
What Thymosin Alpha-1 does in the body
A natural peptide produced by the thymus. It enhances T-cell maturation and function and modulates immune signalling (including toll-like receptors), helping the immune system respond to infections.
Strength of evidence
Moderate: clinical trials for hepatitis and as a vaccine adjunct; mixed results in other conditions.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Injection-site discomfort
- Generally well tolerated in trials
Who should avoid it or take extra care
- Organ transplant recipients on anti-rejection medicines
- Pregnant or breastfeeding
- Autoimmune disease (talk to your doctor first)
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
Approved as Zadaxin in a number of countries outside the US. Not FDA-approved.
How it's taken
Route: Injection under the skin, usually twice a week
How long it lasts (half-life): About 2 hours
Storage
Unreconstituted (powder) vials are usually kept refrigerated or frozen and away from light. Once mixed with bacteriostatic water, keep refrigerated and do not freeze; follow the supplier's stated beyond-use date.
Mixing guides
How much water to add and what each syringe mark holds, worked out for your own dose:
Latest research & news
- Thymosin-α1 for Recurrent Implantation Failure
Clinical trial · Recruiting · Phase 2/3 · Updated · ClinicalTrials.gov · 15 Oct 2026 - Thymalfasin for Immune Recovery in Adults With Sepsis
Clinical trial · Recruiting · Updated · ClinicalTrials.gov · 8 Oct 2026 - Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review
Research · Review · PubMed · Pharmaceuticals (Basel) · 19 Sept 2026 - Protective Effect of Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Clinical trial · Completed · Updated · ClinicalTrials.gov · 14 Sept 2026 - Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
Clinical trial · Not yet recruiting · Phase 2 · Updated · ClinicalTrials.gov · 21 Aug 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Thymosin Alpha-1 privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Thymosin Alpha-1 in Fiala How to installMore in Immune & inflammation
- LL-37The only human cathelicidin: an antimicrobial peptide made by the immune system.
- KPVAnti-inflammatory tripeptide taken from the end of alpha-MSH.
- VIPNeuropeptide that relaxes blood vessels and calms immune responses.
- ARA-290Peptide derived from erythropoietin (EPO), studied for nerve pain and inflammation without raising red blood cells.